Weekly Pharma & Life Science News Round-Up: 5th – 9th December 2022

A round-up of the latest news from the Pharma & Life Science industry; including news from the Pharmaceutical, Clinical Research, Biotechnology and Medical Device sectors from 5^th-9^th December 2022.

Lifecycle Labs Opens Headquarters

Lifecycle Compliance announces the establishment of Lifecycle Labs to meet the growing North Carolina demand for professional microbiology services in the pharmaceutical, biotechnology and healthcare industries.

Olympus Announces the Inaugural Olympus Asia Pacific Innovation Program (OAIP)

Olympus Corporation (Olympus), a global medtech company committed to making people's lives healthier, safer and more fulfilling, has partnered with MedTech Innovator Asia Pacific, the industry's largest healthcare accelerator, to facilitate the OAIP running throughout 2023.

PharmiWeb.Jobs Announces New Partnership With PCMG

PharmiWeb.Jobs is pleased to announce its new partnership with the Pharmaceutical Contract Management Group (PCMG), a unique association of Outsourcing and Procurement professionals working in Research and Development functions across the pharmaceutical industry.

Novotech Awarded the Asia Pacific CRO of the Year 2022 for Best Practices in Clinical Trials

Novotech, the leading Asia Pacific biotech specialist CRO, has been awarded the Frost & Sullivan Company of the Year Award 2022 for Best Practices in the Asia-Pacific contract research organization industry.

Medidata Launches New myMedidata Native App to Expedite Study Start Up and Improve Patient Experience

Medidata, a Dassault Systèmes company, launched a new patient-centric native myMedidata app, designed to provide trial participants with another option for a seamless platform experience and a single login for all their remote trial activities.

Entact Bio Launches with $81 Million Series A to Develop Precision Medicines for Targeted Protein Enhancement

Entact Bio announced it has raised $81 million in Series A financing to advance its proprietary Encompass™ platform for developing enhancement-targeting chimeric (ENTAC™) molecules.

Pfizer and Clear Creek Bio to Collaborate on a Research Program Targeting SARS-CoV-2 Papain-Like Protease

Pfizer Inc. (NYSE: PFE) and Clear Creek Bio, Inc. announced a research collaboration and exclusive license agreement to advance the discovery and development of potential inhibitors of the SARS-CoV-2 papain-like protease (PLpro) for the oral treatment of COVID-19.

AppOmni Announces Partnership With Veeva to Provide Enhanced Data Protection for Life Sciences

AppOmni, the leading provider of SaaS security, today announced a partnership with Veeva Systems to expand SaaS coverage and provide enhanced security for Veeva Vault and Veeva CRM.

PHASTAR Launches Pro-Bono Scheme for Charities

PHASTAR, a global specialist biometrics contract research organization (CRO), has announced the launch of a pro-bono scheme to give charities access to its volunteer statisticians, data scientists, data managers and programmers at no cost.

CALYM and Embleema Announce Partnership to Deploy Next-Generation Clinical Research Solutions for Life Sciences

CALYM Carnot Institute and Embleema, the innovative software provider for patient-driven, regulatory clinical data platforms for precision medicine, today announced a strategic partnership to develop next-generation clinical research solutions aimed at accelerating clinical innovation.

Alliance Pharma Opens State-of-the-Art Bioanalytical Laboratory in Brisbane

Alliance Pharma (Alliance), a global leader providing bioanalytical, DMPK, and CMC testing services in the pharmaceutical and biopharmaceutical industry, has opened its new 20,000-square-foot (1,858-square-meter) bioanalytical laboratory, Alliance Pharma Pty, Ltd., in Brisbane, Australia.

Neuraxpharm expands into the Netherlands

Neuraxpharm Group (Neuraxpharm), a leading European specialty pharmaceutical company focused on the treatment of central nervous system (CNS) disorders, announces the establishment of Neuraxpharm Netherlands.

Emmes Launches Cell and Gene Therapy Center

Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation, announces the creation of a dedicated center to enhance Emmes’ legacy and depth in cell and gene therapy research.

Labcorp Opens New Los Angeles Based Laboratory

Labcorp (NYSE: LH), a leading global life sciences company, announces that it has begun operations at a new, larger anatomic pathology and histology (APH) laboratory in Los Angeles, expanding the company’s global central laboratory capabilities.

Sonde Health Raises $19.25 Million Series B to Build the Next Generation of Voice-Based Health Monitoring

Sonde Health has raised a $19.25 million Series B investment round led by Partners Investment, with participation from NEOM Company, KT Corporation, and existing investors, including co-founder PureTech Health and M Ventures.

AbbVie Launches Strategic Collaboration with HotSpot Therapeutics to Further Expand Immunology Pipeline

AbbVie (NYSE: ABBV) and HotSpot Therapeutics, Inc. announce an exclusive worldwide collaboration and option to license agreement for HotSpot's discovery-stage IRF5 program for the treatment of autoimmune diseases.

MRN presented with the Queen’s Award for Enterprise, International Trade

Medical Research Network, a leading Clinical Trial Organization, was presented with the Queen’s Award for Enterprise, International Trade at a company meeting last night.

Lucid Diagnostics Selected as Finalist for Medtech Company of the Year 2022 by Medical Device + Diagnostic Industry

Lucid Diagnostics Inc announces that the Company was selected as one of ten finalists for the Medtech Company of the Year 2022 by Medical Device + Diagnostic Industry (“MD+DI”), a leading publication serving manufacturers of medical devices and in vitro diagnostics products.

MultiOmic Health forges research collaboration with Northern Care Alliance NHS Foundation Trust in diabetic kidney disease

MultiOmic Health, an artificial intelligence-enabled precision medicine discovery company, announces the signing of a research collaboration agreement with Northern Care Alliance (NCA) NHS Foundation Trust in Manchester, England.